Evidence map›Paper›PMID 41154429›Full record

ReviewCancers2025

Multidisciplinary Perspective of Spread Through Air Spaces in Lung Cancer: A Narrative Review.

Riccardo Orlandi, Lorenzo Bramati, Maria C Andrisani, Giorgio A Croci, Claudia Bareggi, Simona Castiglioni, Francesca Romboni, Sara Franzi, Davide Tosi

Abstract readReview
In one paragraph

Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Pulmonary Squamous Cell Carcinoma Dissemination Through Air Spaces (STAS): Clinicopathologic Findings in Different Tumor Origins.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Riccardo OrlandiDepartment of Thoracic Surgery, University of Milan, 20122 Milan, Italy.ORCID 0000-0002-4113-1598
Lorenzo BramatiDepartment of Thoracic Surgery, University of Milan, 20122 Milan, Italy.
Maria C AndrisaniDepartment of Radiology, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico of Milan, 20122 Milan, Italy.
Giorgio A CrociPathology Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico of Milan, 20122 Milan, Italy.ORCID 0000-0001-5979-7841
Claudia BareggiOncology Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico of Milan, 20122 Milan, Italy.
Simona CastiglioniRadiotherapy Unit, IRCCS Policlinico San Donato, 20097 Milan, Italy.
Francesca RomboniDepartment of Thoracic Surgery, University of Milan, 20122 Milan, Italy.
Sara FranziThoracic Surgery and Lung Transplantation Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico of Milan, 20122 Milan, Italy.
Davide TosiThoracic Surgery and Lung Transplantation Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico of Milan, 20122 Milan, Italy.ORCID 0000-0003-3767-0449

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spread Through Air Spaces (STAS) is an emerging pattern of tumor invasion in lung cancer, first recognized by the World Health Organization in 2015. This narrative review examines STAS from a multidisciplinary perspective, integrating pathologic, radiologic, oncologic, and surgical points of view, together with molecular biology to assess its clinical significance, diagnostic challenges, and therapeutic implications. Pathologically, STAS is characterized by tumor cells floating beyond the main tumor, contributing to recurrence and poor prognosis. Radiologic advancements suggest potential imaging markers for STAS, such as spiculation, the absence of an air bronchogram, solid tumor components, as well as high fluorodeoxyglucose uptake, though definitive preoperative identification remains challenging. Oncologic studies link STAS to aggressive tumor behavior and lympho-vascular invasion, suggesting a role for adjuvant chemotherapy even in the earliest stages of disease; furthermore, specific molecular alterations have been discovered, including EGFR wild-type status and ALK/ROS1 rearrangements together with high Ki-67 expression, tumor necrosis, and alterations in cell adhesion proteins like E-cadherin. Surgical aspects highlight the increased risk of recurrence following limited resection, raising concerns about optimal surgical strategies. The debate over STAS as a true invasion mechanism versus an artifact from surgical handling underscores the need for standardized pathological evaluation. This review aims to refine STAS detection, integrate it into multidisciplinary treatment decision-making, and assess its potential as a staging criterion in lung cancer management.

Indexed as

adjuvant treatmentnon-small cell lung cancerprognosisSTASsurgery

Identifiers

PMID41154429
PMCPMC12563968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.